Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

28 juil. 2025 13h00 HE | Source: DelveInsight Business Research LLP

Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsight

New York, USA, July 28, 2025 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel...
27 sept. 2023 13h00 HE | Source: DelveInsight Business Research LLP

Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho, FibroGen, Sarepta, Capricor, Daiichi Sankyo, Solid Biosciences

New York, USA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho,...
07 sept. 2022 13h00 HE | Source: DelveInsight Business Research LLP

Duchenne Muscular Dystrophy (DMD) Clinical Trial Analysis Featuring 60+ Companies | DelveInsight

New York, USA, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy (DMD) Clinical Trial Analysis Featuring 60+ Companies | DelveInsight Duchenne Muscular Dystrophy pipeline constitutes...